Every Form 4 that BRAINSWAY LTD ORD (BRSYF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BRSYF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BRSYF filings page.
Brainsway Ltd. Chief Technology Officer Moiseyev Gilad reported multiple equity transactions. On May 25, 2026, he exercised stock options for 7,500 Ordinary Shares at an exercise price of NIS 11.17 per share, and the company retained 1,902 shares at NIS 44.04 per share to cover the option exercise.
On June 15, 2026, he sold 5,000 Ordinary Shares in an open-market transaction at a sale price of NIS 42.0397 per share, leaving him with 53,098 Ordinary Shares held directly. Footnotes indicate remaining stock options to purchase 13,125 Ordinary Shares vesting in equal quarterly installments until March 5, 2028, alongside additional unvested RSUs that settle in Ordinary Shares over future dates.
Brainsway Ltd. director Michal Ety Mitrany Rayten reported open-market sales of a total of 17,980 Ordinary Shares over two days. The shares were sold at prices of NIS 45.5588 and NIS 44.7516 per share. Following these transactions, she holds 12,500 Ordinary Shares, including 6,250 unvested RSUs that vest quarterly until March 5, 2028. The Ordinary Shares may also be held as American Depositary Shares, each currently representing one Ordinary Share.
Brainsway Ltd. director Mitrany Rayten Michal Ety exercised stock options for 27,500 Ordinary Shares and settled related taxes with shares. On May 19–20, 2026, 27,500 options with an exercise price of NIS 15.26 per share were exercised, while 9,520 Ordinary Shares were retained by the company at NIS 44.36 and NIS 43.92 per share to cover the exercise price and tax liabilities.
Following these transactions, the director holds 30,480 Ordinary Shares directly, a figure that includes unvested RSUs for 6,250 shares that vest quarterly until March 5, 2028. The Ordinary Shares may also be represented by American Depositary Shares, each currently equal to one Ordinary Share. The filing reflects routine compensation-related activity rather than open‑market buying or selling.